Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 0.86% | 52.99 | 0.9% | $1958.03m | |
| JNJ | Johnson & Johnson | 0.42% | 168.34 | 0.7% | $1218.17m | |
| ABBV | AbbVie, Inc. | 0.84% | 134.21 | 1.9% | $1007.72m | |
| MRK | Merck & Co., Inc. | -0.40% | 79.14 | 0.7% | $922.99m | |
| BMY | Bristol-Myers Squibb Co. | -0.38% | 62.22 | 1.0% | $707.05m | |
| LLY | Eli Lilly & Co. | -0.81% | 237.51 | 1.1% | $629.80m | |
| AZN | AstraZeneca Plc | -1.26% | 57.12 | 1.0% | $260.90m | |
| NVS | Novartis AG | -0.36% | 84.24 | 0.2% | $193.64m | |
| GSK | GlaxoSmithKline Plc | -0.50% | 44.15 | 0.2% | $185.72m | |
| NVO | Novo Nordisk A/S | -2.14% | 93.12 | 0.1% | $158.88m | |
| VTRS | Viatris, Inc. | -0.41% | 14.62 | 0.0% | $135.93m | |
| RGEN | Repligen Corp. | -2.07% | 181.56 | 6.7% | $101.32m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 8.52% | 126.25 | 0.0% | $96.48m | |
| SNY | Sanofi | -0.16% | 51.32 | 0.2% | $69.31m | |
| RPRX | Royalty Pharma Plc | -0.51% | 38.93 | 0.1% | $63.78m |
Company Profile
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.